RAPID RESPONSE: Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules

October 15, 2020 12:30 PM to 2:00 PM

Credits

No CLE

Registration

Fee: Free!

Register Now

Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules

The USPTO published a Final Rule for "Setting and Adjusting Patent Fees During Fiscal Year 2020" on August 3, 2020, in a Federal Register Notice, announcing fee changes that take effect October 2, 2020. However, the Final Rule contained more than just the usual fee raises. The Final Rule established three other important changes for patent practitioners that could be missed without a careful review, and went largely unnoticed by the patent community. This webinar will provide information about these changes that take effect starting in 2022, including a non-DOCX filing surcharge, a new biennial patent practitioner registration statement requirement, and a voluntary CLE certification for registered practitioners. Speakers will explore the details outlined in the August 3 Final Rule, details that still need clarification by the USPTO, and potential implications for patent applicants and practitioners.


Moderator:

Brian Stanton, Stanton Consulting Services

Speakers:

Terry Clark, Bass, Berry & Sims – Biennial Registration Statement

Theresa Stadheim, Mueting Raasch Group – Voluntary CLE Certification

Brad Forrest, Schwegman Lundberg & Woessner, P.A. – Non-DOCX Filing Surcharge

Add to:

 

 

News

  • TermDisc-Comments-March21-logo AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination

    April 1, 2026

    Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents.
  • AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc

    March 31, 2026

    Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods.
  • Supreme Court Issues Unanimous Decision in Cox Communications, Inc. v. Sony Music Entertainment

    March 25, 2026

    On March 25, 2026, the Supreme Court issued a unanimous decision in Cox Communications, Inc. v. Sony Music Entertainment. The majority opinion limits contributory liability to situations where a party intended that its service be used for infringement, either by affirmatively inducing infringement or by selling a service tailored to infringement. A concurring opinion by Justice Sotomayor argues that the material contribution test should be retained, and that other forms of secondary liability can be found, which is consistent with the position asserted by AIPLA in its amicus brief filed on September 5, 2025. To read the opinion of the Court, please click here.
  • Writing AIPLA Comments on the Draft Trademark Law of the People’s Republic of China

    March 23, 2026

    Arlington, VA. February 9, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the Legislative Affairs Commission of the Standing Committee of the National People’s Congress regarding the latest Draft Trademark Law of the People’s Republic of China. AIPLA recognized the NPC’s efforts to streamline trademark procedures, strengthen protection, and address abusive and bad-faith filing practices.
  • AIPLA Files Amicus Brief in USAA v. PNC Bank

    March 3, 2026

    Arlington, VA. March 2, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Supreme Court in USAA v. PNC Bank, N.A., No. 25-853, in support of USAA’s petition for certiorari, urging the Court to provide much-needed guidance to address the unpredictable and overly broad application of the judicial exceptions to patent-eligible subject matter under 35 U.S.C. § 101, particularly the “abstract idea” exception.